Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men
Crossref DOI link: https://doi.org/10.1007/s40261-017-0547-7
Published Online: 2017-06-28
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Olsson, HÃ¥kan https://orcid.org/0000-0001-7647-0381
Petri, Niclas
Erichsen, Lars
Malmberg, Anders
Grundemar, Lars
Funding for this research was provided by:
Ferring Pharmaceuticals A/S
License valid from 2017-06-28